ESMO Sarcoma and Rare Cancers Congress 2023

Presentations (slides) and webcasts are available to ESMO Members and registered delegates according to the presenters' agreement to release them.

The copyright protected educational resources from this event are for personal usage only and not to be shared with any third parties. ESMO thanks the authors for their generosity.

The Programme provided insights into the diagnosis, prognostication, management and ongoing research of patients with rare adult solid cancers. Educational and scientific sessions covered State-of-the-art multidisciplinary management of patients affected by the 10 families of rare solid tumours, insights into the biology, molecular classification and diagnostics of sarcomas and rare cancers, and latest research data focusing on precision therapeutics for rare cancers and some rare molecular subgroups of common cancers.